持田製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2021/05/14 | 3,770 | 3,845 | 3,725 | 3,755 | +40 | +1.1% | 58,700 |
| 2021/05/13 | 3,780 | 3,820 | 3,715 | 3,715 | -65 | -1.7% | 49,000 |
| 2021/05/12 | 3,810 | 3,835 | 3,770 | 3,780 | -70 | -1.8% | 43,200 |
| 2021/05/11 | 3,900 | 3,940 | 3,840 | 3,850 | -90 | -2.3% | 41,900 |
| 2021/05/10 | 3,840 | 3,940 | 3,840 | 3,940 | +85 | +2.2% | 25,000 |
| 2021/05/07 | 3,875 | 3,900 | 3,855 | 3,855 | ±0 | ±0% | 19,300 |
| 2021/05/06 | 3,850 | 3,935 | 3,850 | 3,855 | +50 | +1.3% | 36,800 |
| 2021/04/30 | 3,830 | 3,870 | 3,805 | 3,805 | -15 | -0.4% | 37,300 |
| 2021/04/28 | 3,880 | 3,890 | 3,820 | 3,820 | -60 | -1.5% | 39,200 |
| 2021/04/27 | 3,935 | 3,940 | 3,880 | 3,880 | -40 | -1% | 32,100 |
| 2021/04/26 | 4,010 | 4,010 | 3,920 | 3,920 | -55 | -1.4% | 25,100 |
| 2021/04/23 | 4,005 | 4,035 | 3,975 | 3,975 | -80 | -2% | 20,500 |
| 2021/04/22 | 4,015 | 4,065 | 4,015 | 4,055 | +75 | +1.9% | 45,400 |
| 2021/04/21 | 3,980 | 4,020 | 3,955 | 3,980 | -35 | -0.9% | 45,800 |
| 2021/04/20 | 4,050 | 4,055 | 4,000 | 4,015 | -35 | -0.9% | 44,100 |
| 2021/04/19 | 4,060 | 4,075 | 4,045 | 4,050 | +5 | +0.1% | 23,500 |
| 2021/04/16 | 4,060 | 4,090 | 4,045 | 4,045 | -10 | -0.2% | 15,300 |
| 2021/04/15 | 4,070 | 4,080 | 4,055 | 4,055 | -15 | -0.4% | 15,200 |
| 2021/04/14 | 4,120 | 4,120 | 4,050 | 4,070 | -65 | -1.6% | 26,400 |
| 2021/04/13 | 4,170 | 4,200 | 4,125 | 4,135 | -5 | -0.1% | 28,900 |
| 2021/04/12 | 4,205 | 4,205 | 4,135 | 4,140 | -25 | -0.6% | 49,300 |
| 2021/04/09 | 4,170 | 4,205 | 4,150 | 4,165 | +35 | +0.8% | 29,800 |
| 2021/04/08 | 4,210 | 4,210 | 4,130 | 4,130 | -115 | -2.7% | 43,100 |
| 2021/04/07 | 4,205 | 4,270 | 4,195 | 4,245 | +45 | +1.1% | 30,500 |
| 2021/04/06 | 4,300 | 4,325 | 4,185 | 4,200 | -100 | -2.3% | 45,400 |
| 2021/04/05 | 4,290 | 4,320 | 4,275 | 4,300 | +25 | +0.6% | 30,700 |
| 2021/04/02 | 4,340 | 4,340 | 4,270 | 4,275 | -10 | -0.2% | 14,400 |
| 2021/04/01 | 4,290 | 4,320 | 4,260 | 4,285 | -5 | -0.1% | 26,800 |
| 2021/03/31 | 4,310 | 4,350 | 4,285 | 4,290 | -90 | -2.1% | 45,600 |
| 2021/03/30 | 4,500 | 4,500 | 4,355 | 4,380 | -180 | -3.9% | 45,000 |
| 2021/03/29 | 4,565 | 4,565 | 4,490 | 4,560 | +80 | +1.8% | 73,200 |
| 2021/03/26 | 4,440 | 4,495 | 4,395 | 4,480 | +85 | +1.9% | 36,600 |
| 2021/03/25 | 4,440 | 4,440 | 4,335 | 4,395 | +25 | +0.6% | 47,100 |
| 2021/03/24 | 4,520 | 4,540 | 4,360 | 4,370 | -205 | -4.5% | 51,300 |
| 2021/03/23 | 4,700 | 4,700 | 4,575 | 4,575 | -120 | -2.6% | 30,700 |
| 2021/03/22 | 4,620 | 4,725 | 4,595 | 4,695 | +45 | +1% | 56,600 |
| 2021/03/19 | 4,665 | 4,665 | 4,615 | 4,650 | -5 | -0.1% | 84,600 |
| 2021/03/18 | 4,705 | 4,720 | 4,610 | 4,655 | -40 | -0.9% | 57,700 |
| 2021/03/17 | 4,610 | 4,705 | 4,610 | 4,695 | +55 | +1.2% | 46,200 |
| 2021/03/16 | 4,530 | 4,645 | 4,515 | 4,640 | +140 | +3.1% | 79,800 |
| 2021/03/15 | 4,405 | 4,505 | 4,405 | 4,500 | +145 | +3.3% | 57,600 |
| 2021/03/12 | 4,370 | 4,395 | 4,335 | 4,355 | -60 | -1.4% | 79,500 |
| 2021/03/11 | 4,310 | 4,415 | 4,300 | 4,415 | +95 | +2.2% | 59,300 |
| 2021/03/10 | 4,290 | 4,355 | 4,270 | 4,320 | +15 | +0.3% | 51,300 |
| 2021/03/09 | 4,220 | 4,305 | 4,190 | 4,305 | +155 | +3.7% | 73,500 |
| 2021/03/08 | 4,150 | 4,175 | 4,115 | 4,150 | +10 | +0.2% | 42,900 |
| 2021/03/05 | 4,090 | 4,140 | 4,060 | 4,140 | +70 | +1.7% | 48,000 |
| 2021/03/04 | 4,035 | 4,080 | 4,030 | 4,070 | -5 | -0.1% | 31,800 |
| 2021/03/03 | 4,030 | 4,075 | 4,000 | 4,075 | +60 | +1.5% | 46,000 |
| 2021/03/02 | 4,005 | 4,030 | 3,965 | 4,015 | +10 | +0.2% | 65,800 |
1051～
1100
件表示中 / 3770件
類似銘柄と比較する
現在ご覧いただいている「持田薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 持田薬 | 311,500円 | +5.1% | -7.0% | 2.57% | 20.45倍 | 0.84倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| 東和薬品 | 311,500円 | +7.9% | -3.3% | 2.57% | 8.66倍 | 0.89倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
| ジーエヌアイ | 265,700円 | +21.7% | +999.9% | 0.00% | 12.24倍 | 4.19倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| ゼリア新薬 | 204,700円 | +3.1% | -6.5% | 2.34% | 9.50倍 | 1.01倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| 栄研化 | 241,900円 | +4.1% | -3.1% | 2.40% | 21.01倍 | 1.83倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割。尿検査（ウロ）、遺伝子検査も育成 |
市場注目の銘柄
チャート関連のコラム
